About Careers MedBlog Contact us
Medindia LOGIN REGISTER
Advertisement

Research Says Targeted Cancer Drug More Effective After First-Line Treatment

by Kathy Jones on March 1, 2011 at 6:25 PM
Font : A-A+

 Research Says Targeted Cancer Drug More Effective After First-Line Treatment

Targeted cancer drug Erlotinib has comparable efficacy to chemotherapy, and is better tolerated, in hard-to-treat cases where a patient's cancer has progressed quickly after treatment with first-line therapy, new trials have found.

The study included only those patients whose disease had progressed under first-line chemotherapy.

Advertisement

"These patients have an extremely poor prognosis and few treatment options. An effective alternative to chemotherapy is therefore very important, since chemo-related side-effects can result in further physical deterioration in patients who are already very sick," said Tudor Ciuleanu from the Institute of Oncology Ion Chiricuta, Cluj-Napoca, Romania.

Historically, data has shown that Erlotinib was more tolerable than chemotherapy, but many physicians had assumed that Erlotinib would not be as effective in this difficult-to-treat patient population compared to chemotherapy.
Advertisement

The open-label study included 424 patients whose lung cancer had progressed rapidly after treatment with first-line chemotherapy. Of these, 203 were treated with erlotinib, and 221 received chemotherapy with either docetaxel or pemetrexed.

No difference in overall survival was seen between the two groups, the researchers reported. Nor was there any significant difference in progression-free survival time.

"TITAN is important because it confirms that erlotinib has comparable efficacy to chemotherapy with better tolerability, even in this population of patients with poor prognosis," said Ciuleanu.

"The study included a broad, unselected population, showing that patients can benefit from erlotinib regardless of their EGFR mutation status. Erlotinib therefore gives doctors an effective alternative to chemotherapy after disease progression, without chemo-related side-effects," added Ciuleanu.

The findings were discussed at the international TITAN study at the European Multidisciplinary Conference in Thoracic Oncology in Lugano, Switzerland.

Source: ANI
Advertisement

Advertisement
News A-Z
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
What's New on Medindia
Test  Your Knowledge on Heart
Test Your Knowlege on Genes
Obesity in Teens Make Inroads into Early Atrial Fibrillation
View all
Recommended Reading
News Archive
Date
Category
Advertisement
News Category

Medindia Newsletters Subscribe to our Free Newsletters!
Terms & Conditions and Privacy Policy.

More News on:
Drug Toxicity Cancer and Homeopathy Signature Drug Toxicity Cancer Facts Cancer Tattoos A Body Art Oncology Drug Delivery Systems Common Lifestyle Habits that Cause Diseases Health Benefits of Dandelion Plant Immune Checkpoint Inhibitors for Cancer Treatment 

Most Popular on Medindia

Turmeric Powder - Health Benefits, Uses & Side Effects Accident and Trauma Care Find a Hospital Drug Side Effects Calculator Sanatogen The Essence of Yoga Noscaphene (Noscapine) Nutam (400mg) (Piracetam) Sinopril (2mg) (Lacidipine) Pregnancy Confirmation Calculator
This site uses cookies to deliver our services. By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use
×

Research Says Targeted Cancer Drug More Effective After First-Line Treatment Personalised Printable Document (PDF)

Please complete this form and we'll send you a personalised information that is requested

You may use this for your own reference or forward it to your friends.

Please use the information prudently. If you are not a medical doctor please remember to consult your healthcare provider as this information is not a substitute for professional advice.

Name *

Email Address *

Country *

Areas of Interests